Clinical trial
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone…
NCT00362973 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00362973 |
|---|---|
| Title | PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer |
| Official title | Early Assessment of Response to Targeted Breast Cancer Therapy |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Other, Procedure, Radiation |
| Interventions | laboratory biomarker analysis, needle biopsy, positron emission tomography, radionuclide imaging, fludeoxyglucose F 18 |
| Enrollment | 42 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2009 |
| First posted | Aug 15, 2006 |
| Last update posted | Dec 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: